Every diagnostic system has to be tested for potential interfering factors during development. For this essential step in assay validation, we have put together ideally composed collections of human biospecimens. The interfering factors of an in vitro diagnostic test (IVD) can be analysed with the panel of interfering substances, which is available here. Besides an interference panel, biospecimen collections of patients with rheumatoid arthritis, diabetes (type I and II) and obesity are available. Panels of pregnant women and elderly people cover other potentially interfering factors during assay development. If you do not find the panel you are looking for, please contact our Central BioHub team.
SARS-CoV-2 positive Plasma Panel (10 Samples: 1 mL each)
< -15 Â°C
Each individual donation was tested with methods cleared in compliance with European Directive 98/79/EC and found negative for HBsAg, anti-HIV I+II, anti-HCV, HIV I RNA, HCV RNA, HBV DNA, HCV RNA, Syphilis. SARS-CoV-2 IgG and IgM values available.
Ref. / Cut-Off
Remarks: For Details see Product Data Sheet: https://inventdiagnostica.de/wp-content/uploads/2020/07/PD-SARS-CoV-2-positive-Plasma-Panel-DSPA-18.104.22.168.1.pdf
All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
Molecular genetic tests that establish the donor's identity are prohibited.
Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
An import permit for biological substances may be required, in which case it must be present for purchase.
10 mL (€2,250.00)
Will be delivered in 16 to 20 Business Days (€180.00)